KalVista Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US4834971032

Introduction

This page provides a comprehensive analysis of the known insider trading history of Feener Edward P.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Feener Edward P. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:KALV / KalVista Pharmaceuticals, Inc. CHIEF SCIENTIFIC OFFICER 72,858
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Feener Edward P.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases KALV / KalVista Pharmaceuticals, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in KALV / KalVista Pharmaceuticals, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

KALV / KalVista Pharmaceuticals, Inc. Insider Trades
Insider Sales KALV / KalVista Pharmaceuticals, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in KALV / KalVista Pharmaceuticals, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2024-05-20 KALV Feener Edward P. 8,088 11.7645 8,088 11.7645 95,151 239 7.4000 -35,300 -37.10
2024-02-20 KALV Feener Edward P. 8,397 14.1148 8,397 14.1148 118,522
2024-02-14 KALV Feener Edward P. 28,171 15.0093 28,171 15.0093 422,827
2023-11-20 KALV Feener Edward P. 4,958 8.2293 4,958 8.2293 40,801
2023-08-18 KALV Feener Edward P. 4,976 10.7287 4,976 10.7287 53,386
2023-05-18 KALV Feener Edward P. 1,786 10.1444 1,786 10.1444 18,118
2023-02-17 KALV Feener Edward P. 2,228 7.6600 2,228 7.6600 17,066
2022-11-18 KALV Feener Edward P. 530 5.4400 530 5.4400 2,883
2022-08-17 KALV Feener Edward P. 532 14.9619 532 14.9619 7,960

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

KALV / KalVista Pharmaceuticals, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Feener Edward P. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-05-21 2024-05-20 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale -8,088 72,858 -9.99 11.76 -95,151 857,138
2024-05-21 2024-05-17 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
M - Exercise 18,789 80,946 30.23
2024-02-21 2024-02-20 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -300 62,157 -0.48 14.72 -4,416 914,951
2024-02-21 2024-02-20 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -19,591 62,457 -23.88 14.04 -274,991 876,684
2024-02-21 2024-02-20 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale -8,397 82,048 -9.28 14.11 -118,522 1,158,091
2024-02-21 2024-02-17 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
M - Exercise 18,788 90,445 26.22
2024-02-16 2024-02-14 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale -28,171 71,657 -28.22 15.01 -422,827 1,075,521
2024-02-13 2024-02-11 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
A - Award 60,000 99,828 150.65
2024-01-12 2024-01-11 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -22,679 39,828 -36.28 13.03 -295,514 518,971
2024-01-10 2024-01-09 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -100 62,507 -0.16 13.00 -1,300 812,591
2024-01-10 2024-01-08 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -17,221 62,607 -21.57 13.01 -224,000 814,354
2023-11-21 2023-11-20 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale -4,958 79,828 -5.85 8.23 -40,801 656,929
2023-11-21 2023-11-17 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
M - Exercise 11,497 84,786 15.69
2023-08-21 2023-08-18 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale -4,976 73,289 -6.36 10.73 -53,386 786,296
2023-08-21 2023-08-17 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
M - Exercise 11,494 78,265 17.21
2023-05-19 2023-05-18 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale -1,786 66,771 -2.61 10.14 -18,118 677,352
2023-05-19 2023-05-17 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
M - Exercise 4,205 68,557 6.53
2023-02-23 2023-02-17 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale -2,228 64,352 -3.35 7.66 -17,066 492,936
2023-02-23 2023-02-17 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
M - Exercise 4,204 66,580 6.74
2022-11-21 2022-11-18 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale -530 62,376 -0.84 5.44 -2,883 339,325
2022-11-21 2022-11-17 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
M - Exercise 1,774 62,906 2.90
2022-08-19 2022-08-17 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale -532 61,132 -0.86 14.96 -7,960 914,651
2022-08-19 2022-08-17 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
M - Exercise 1,773 61,664 2.96
2022-05-19 2022-05-17 4 KALV KalVista Pharmaceuticals, Inc.
Restricted Stock Units
A - Award 28,380 28,380
2022-05-19 2022-05-17 4 KALV KalVista Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
A - Award 18,920 18,920
2022-01-11 2022-01-07 4 KALV KalVista Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -23,857 27,943 -46.06
2022-01-11 2022-01-07 4 KALV KalVista Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -33,800 0 -100.00
2022-01-11 2022-01-07 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
M - Exercise 23,857 59,891 66.21 8.21 195,866 491,705
2022-01-11 2022-01-07 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
M - Exercise 33,800 36,034 1,512.98 7.07 238,966 254,760
2021-11-03 2021-11-01 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -6,000 2,234 -72.87 18.07 -108,424 40,370
2021-08-04 2021-08-02 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -6,000 8,234 -42.15 20.52 -123,134 168,981
2021-06-03 2021-06-02 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -1,062 14,234 -6.94 27.05 -28,723 384,974
2021-06-03 2021-06-02 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -7,138 15,296 -31.82 26.33 -187,973 402,806
2021-06-03 2021-06-01 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -14 22,434 -0.06 27.21 -381 610,454
2021-06-03 2021-06-01 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -25,786 22,448 -53.46 26.81 -691,284 601,797
2021-05-28 2021-05-26 4 KALV KalVista Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
A - Award 60,000 60,000
2021-05-07 2021-05-03 4/A KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -6,000 48,234 -11.06 24.84 -149,051 1,198,219
2021-05-06 2021-05-03 4 KALV KalVista Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -6,000 20,255 -22.85
2021-05-06 2021-05-03 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -6,000 54,234 -9.96 24.84 -149,051 1,347,270
2021-05-06 2021-05-03 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
M - Exercise 6,000 60,234 11.06 10.21 61,260 614,989
2021-02-25 2021-02-23 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -800 54,234 -1.45 31.73 -25,384 1,720,861
2021-02-25 2021-02-23 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -5,471 55,034 -9.04 32.97 -180,400 1,814,680
2021-02-25 2021-02-23 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -23,441 60,505 -27.92 33.72 -790,534 2,040,495
2021-02-25 2021-02-23 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -1,288 83,946 -1.51 35.19 -45,325 2,954,068
2021-02-08 2021-02-07 4 KALV KalVista Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2021-02-08 2021-02-07 4 KALV KalVista Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 22,500 22,500
2021-02-08 2021-02-07 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
A - Award 12,500 85,234 17.19
2020-12-18 2020-12-16 4 KALV KalVista Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 65,000 65,000
2020-11-04 2020-11-02 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -6,000 72,734 -7.62 17.14 -102,812 1,246,319
2020-10-22 2020-10-21 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -5,407 78,734 -6.43 18.75 -101,374 1,476,160
2020-10-22 2020-10-21 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -3,600 84,141 -4.10 17.65 -63,554 1,485,417
2020-10-22 2020-10-20 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -2,300 87,741 -2.55 18.00 -41,407 1,579,601
2020-10-22 2020-10-20 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -5,600 90,041 -5.86 17.26 -96,683 1,554,549
2020-10-20 2020-10-16 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -993 95,641 -1.03 17.00 -16,881 1,625,897
2020-02-07 2020-02-05 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -100 96,634 -0.10 17.11 -1,711 1,653,408
2019-07-24 2019-07-23 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -1,900 96,734 -1.93 18.65 -35,439 1,804,292
2019-07-24 2019-07-22 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -1,400 98,634 -1.40 18.57 -26,004 1,832,058
2019-05-17 2019-05-15 4 KALV KalVista Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
A - Award 20,250 20,250
2019-04-18 2019-04-17 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -916 100,034 -0.91 25.39 -23,260 2,540,183
2019-04-18 2019-04-17 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -3,084 100,950 -2.96 24.78 -76,406 2,501,036
2019-01-18 2019-01-16 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -2,300 104,034 -2.16 19.81 -45,572 2,061,340
2019-01-18 2019-01-16 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
S - Sale X -1,700 106,334 -1.57 19.20 -32,637 2,041,453
2018-09-20 2018-09-18 4 KALV KalVista Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
A - Award 52,600 52,600
2018-09-20 2018-09-18 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
F - Taxes -2,500 108,034 -2.26 17.05 -42,625 1,841,980
2018-09-20 2018-09-18 4 KALV KalVista Pharmaceuticals, Inc.
Common Stock
A - Award 12,500 110,534 12.75
2018-06-06 2018-06-04 4 KALV KalVista Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
A - Award 51,800 51,800
2017-05-26 2017-05-25 4 KALV KalVista Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
A - Award 33,800 33,800
2016-11-30 2016-11-28 4 KALV KalVista Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
A - Award 20,055 20,055
2016-11-30 3 KALV KalVista Pharmaceuticals, Inc.
Common Stock
196,068
2016-11-30 3 KALV KalVista Pharmaceuticals, Inc.
Common Stock
196,068
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)